RT Journal Article
SR Electronic
T1 2020 Year in Review: Pharmacologic Treatments for COVID-19
JF Respiratory Care
FD American Association for Respiratory Care
SP 1167
OP 1172
DO 10.4187/respcare.09153
VO 66
IS 7
A1 Jessica L Saunders
A1 Michael D Davis
YR 2021
UL http://rc.rcjournal.com/content/66/7/1167.abstract
AB Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 infection, has led to a pandemic of acute respiratory illness. Pharmacologic treatments for COVID-19 have included treatments that target infection prevention, prevention of viral replication, reduce inflammation, and manage symptoms of respiratory failure caused by the disease. This is a review of key pharmacologic treatments for COVID-19 based on peer-reviewed articles from 2020.